Research programme: neuronal nicotinic receptor agonists - AbbVieAlternative Names: A-366833; A-582941; A-844606; A-85380; A-859261; A-867744; A-870022; A-880006; A-988056
Latest Information Update: 23 Jan 2013
At a glance
- Originator Abbott Laboratories
- Developer AbbVie
- Class Azetidines; Indoles; Pyridines; Pyrroles; Small molecules
- Mechanism of Action Alpha7 nicotinic acetylcholine receptor agonists; Nicotinic receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cognition disorders; Pain